PExA AB

PExA develops methods for collection of biomarkers. The company provides collection and measuring instruments, consumables, and other analytical services for the examination of patients’ lungs. The products are primarily used in the treatment of airway diseases, such as asthma and chronic obstructive pulmonary disease, COPD. In addition to the main business, also service and support is offered. The company was founded in 2014 and is based in Gothenburg.

Quotes for PExA AB

Right Now

+/-
%
Latest
High
Low
Volume
Turnover ()
Time (Latest trade)

Board

CEO

  • Tomas Gustafsson

Chairperson of the Board

  • Claes Holmberg

Board

  • Anna-Carin Olin
  • Björn Dahlöf
  • Martin Malmström
  • Articles of association

    • News

    Show More

    News agencies

    Show More

    Analysis

    Videos

    PExA

    Intervju med VD, Tomas Gustafsson

    Lifesciencedagen 2025 - Pexa

    Pexa

    Largest Owners

    Name Capital % Votes % Date
    Sven Christer Andersson 18,40 17,24 2025-06-26
    Nordnet Pensionsförsäkring 12,42 11,64 2025-06-26
    Avanza Pension 11,39 10,67 2025-06-26
    Ola Hermansson 4,15 4,26 2025-06-26
    Anna-Carin Olin 2,86 7,44 2025-06-26
    Per Berger 2,58 2,41 2025-06-26
    Jan Emander 1,98 1,86 2025-06-26
    Jimmy Biesért 1,39 1,30 2025-06-26
    Mikael Blihagen 1,26 1,18 2025-06-26
    Patrick Svensson 1,25 1,17 2025-06-26
    ** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

    Insider trading

    *Source: Holdings by Modular Finance AB. Compiled and processed data from the Swedish Financial Supervisory Authority

    Key Numbers

    *Compiled data from Millistream

    Upcoming reports

    • 2025-11-07 Delårsrapport 2025-Q3

    • 2026-02-19 Bokslutskommuniké 2025

    Annual reports, prospectus etc.